Fresenius Medical Care Demonstrates Commitment to Innovating Dialysis and Kidney Disease Care with Presentations at the American Society of Nephrology (ASN) Kidney Week 2023
Retrieved on:
Tuesday, October 31, 2023
Kidney, Frankfurt Stock Exchange, Patient, Hemofiltration, Research, FME, Intelligence, III, HDF, Assessment of kidney function, AVF, Big data, Fatigue, HD, American Society of Nephrology, Saskatchewan River Sturgeon Management Board, Arteriovenous fistula, FX, Health, Society, Artificial intelligence, Dialysis, PO4, PSM, COVID-19, ASN, Machine learning, Congress, Fresenius Medical Care, FKC, RBV, Creatinine, Scientific Committee on Oceanic Research, FMS, Peritoneum, IDS, Data science, Pharmaceutical industry, Medical device, Hemodialysis, Nephrology
Fresenius Medical Care announces presentations at the American Society of Nephrology (ASN) Kidney Week 2023.
Key Points:
- Fresenius Medical Care announces presentations at the American Society of Nephrology (ASN) Kidney Week 2023.
- Scientific and medical experts from across Fresenius Medical Care will present research related to many important topics in kidney disease care.
- Through its network of 4,050 dialysis clinics, Fresenius Medical Care provides dialysis treatments for approximately 344,000 patients around the globe.
- Fresenius Medical Care AG & Co. KGaA does not undertake any responsibility to update the forward-looking statements in this release.